Cygnus sells drug delivery business to Ortho-McNeil
This article was originally published in Clinica
Cygnus has completed the sale of its drug delivery business to Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. The Redwood City, California-based company could receive up to $75 million in cash from Ortho-McNeil, which it says will allow it "to focus management attention and corporate resources on our glucose monitoring business".
You may also be interested in...
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.